Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Authors Respond.

Epidemiology (Cambridge, Mass.)·2026
Same author

Genome-wide meta-analysis identifies genetic drivers of bile acid metabolism in intrahepatic cholestasis of pregnancy.

Nature communications·2026
Same author

Genetic architecture of lumbar spinal stenosis.

Nature communications·2026
Same author

Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study.

Research square·2026
Same author

Higher hemoglobin levels within reference interval are associated with elevated cardiometabolic traits in a birth cohort of 16-yr-old adolescents.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Assessing the Causal Effects of Environmental Tobacco Smoke Exposure: A meta-analytic Mendelian randomisation study.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026

Related Experiment Video

Updated: Mar 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K

PCSK9 and Breast Cancer Survival: A Mendelian Randomization Study.

Janne Pott1, Amy M Mason2,3, Ville Salo4

  • 1MRC Biostatistics Unit , University of Cambridge, Cambridge, United Kingdom.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|March 23, 2026
PubMed
Summary
This summary is machine-generated.

This study found no significant association between PCSK9 gene variants and breast cancer survival (BCS) in independent, larger genome-wide association studies (GWAS). Further research is needed before considering PCSK9 inhibition as a therapeutic target for breast cancer.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K

Related Experiment Videos

Last Updated: Mar 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K

Area of Science:

  • Genetics and Genomics
  • Oncology
  • Metabolic Diseases

Background:

  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a role in lipid metabolism.
  • A prior study suggested a link between a PCSK9 gene variant (rs562556) and breast cancer survival (BCS), proposing PCSK9 inhibition for cancer prevention.
  • This study aimed to validate these findings using large-scale genome-wide association study (GWAS) data and Mendelian Randomization (MR).

Purpose of the Study:

  • To replicate the association between PCSK9 variants and breast cancer survival (BCS).
  • To investigate PCSK9 inhibition as a potential therapeutic strategy for breast cancer.
  • To assess the reliability of reported associations using independent genetic data.

Main Methods:

  • Utilized GWAS data from the Breast Cancer Association Consortium (BCAC, N=91,686) and the FinnGen study (N=4,648).
  • Employed Mendelian Randomization (MR) approaches, including single-variant, multiple-variant, and multivariable MR analyses.
  • Adjusted for potential indirect effects of lipid metabolism and used coronary artery disease as a positive control.

Main Results:

  • No significant association was found between PCSK9 variants and BCS across all MR approaches and replication datasets.
  • Estimates were consistently non-significant when analyzing single variants, multiple variants, or adjusting for lipid metabolism.
  • Positive control analyses for coronary artery disease yielded significant results, confirming the validity of the MR methods.

Conclusions:

  • The previously reported association between PCSK9 variants and BCS could not be reproduced in independent, larger GWAS datasets.
  • Discrepancies may stem from differences in genetic models, sample characteristics, or time-varying hazard ratio estimates.
  • PCSK9 inhibition cannot be recommended as a therapeutic target for breast cancer patients without further investigation.